NXGL
Nexgel Inc
NASDAQ: NXGL · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$0.59
-1.63% today
Updated 2026-04-30
Market cap
$5.14M
P/E ratio
—
P/S ratio
0.45x
EPS (TTM)
$-0.38
Dividend yield
—
52W range
$1 – $3
Volume
0.4M
Nexgel Inc (NXGL) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-26.30%
Operating margin
-43.40%
ROE
-52.70%
ROA
-19.50%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2016 | $2.15M | $-1.78M | -5.30% | -86.62% | -82.53% |
| 2017 | $1.99M | $-953000.00 | 7.38% | -48.64% | -47.84% |
| 2018 | $2.21M | $-1.89M | 23.23% | -85.31% | -85.31% |
| 2019 | $717000.00 | $-1.92M | -19.11% | -268.34% | -268.20% |
| 2020 | $674000.00 | $-2.26M | -43.18% | -335.31% | -335.91% |
| 2021 | $1.55M | $-4.31M | 0.52% | -165.70% | -277.89% |
| 2022 | $2.05M | $-4.75M | 12.50% | -163.48% | -231.74% |
| 2023 | $4.09M | $-3.16M | 9.15% | -85.03% | -77.21% |
| 2024 | $8.69M | $-3.28M | 31.63% | -40.91% | -37.76% |
| 2025 | $11.42M | $-3.00M | 39.48% | -29.35% | -26.27% |